Home/Filings/4/0001562180-25-005201
4//SEC Filing

Ostrowski Erik 4

Accession 0001562180-25-005201

CIK 0001517022other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 5:01 PM ET

Size

5.2 KB

Accession

0001562180-25-005201

Insider Transaction Report

Form 4
Period: 2025-06-30
Ostrowski Erik
SVP, CFO, CBO & Treasurer
Transactions
  • Sale

    Common Stock

    2025-06-30$3.67/sh41,314$151,622503,586 total
Footnotes (2)
  • [F1]This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 21, 2024.
  • [F2]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on June 28, 2024.

Issuer

Akebia Therapeutics, Inc.

CIK 0001517022

Entity typeother

Related Parties

1
  • filerCIK 0001762507

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:01 PM ET
Size
5.2 KB